Liposomal Versus Conventional Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas: Observational Multi-Institutional Cohort of 8.5-Year Experience
Year: 2026
Type: article
Study design: Observational Study
Source: JCO Oncology Practice
DOI: 10.1200/op-26-00132
Institutions: University of Pennsylvania, Yale Cancer Center, Yale University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154584147